Autism is characterized by impaired reciprocal social interaction and communication and restricted and stereotyped patterns of interests and activities 1 . Asperger syndrome is characterized by higher cognitive abilities and more normal language function 2 . The recurrence risk of autism in siblings is approximately 45 times greater than in the general population, and twin studies have documented a higher concordance rate in monozygotic (60-91%) than in dizygotic twins (0-6%; ref. 3) . The male-to-female ratio is 4:1 in autism and 8:1 in Asperger syndrome. Male predisposition to autistic disorder has not been explained, although abnormalities of the sex chromosomes are frequently associated with autistic spectrum disorders 4 . At least two loci on the X chromosome have been suggested to be associated with a predisposition to autism. At Xp22.3 de novo chromosomal deletions have been observed in three autistic females 5 , and a second locus at Xq13-21 has shown greater allele sharing around markers DXS7132 (52 cM) and DXS6789 (62 cM) in analyses of pairs of affected siblings in two independent genome scans 6, 7 .
Within the deleted interval on Xp22.3, we identified the transcript KIAA1260, which corresponds to NLGN4, a member of the neuroligin family 8 . Notably, NLGN3 (ref. 9), a homolog of NLGN4, is located at Xq13 (55-56 cM) within the second locus on chromosome X associated with autism. These genes encode celladhesion molecules present at the postsynaptic side of the synapse 10, 11 and may be essential factors for the formation of functional synapses 12 . Five genes encoding neuroligins have been identified in the human genome, localized at 3q26 (NLGN1), 17p13 (NLGN2), Xq13 (NLGN3), Xp22.3 (NLGN4) and Yq11.2 (NLGN4Y). Neuroligin phylogeny suggests that NLGN3 is the common ancestor with NLGN4 and NLGN4Y (data not shown). Sequence comparison showed that all amino acids known to be essential for neuroligins are conserved in NLGN4 and NLGN4Y, including the cysteines, the transmembrane domain and the postsynaptic density 95-discs large-zona occludens-1 (PDZ) binding domain.
We determined the expression profiles of NLGN genes by specific RT-PCR in individual male and female adult brain tissues ( Fig. 1) . We sequenced all RT-PCR products and found that they correspond to alternative splicing isoforms. We detected transcripts from NLGN1, NLGN2 and NLGN3 in all brain regions. We detected NLGN4 and NLGN4Y at similar levels in male brains, with no considerable differences in regional distribution. There is an alternative promoter 693 bp downstream of NLGN4 exon 1a, in which exon 1b is substituted in place of exon 1a. Exon 1b is specific to NLGN4 and contains an alternative donor-splice site.
We screened for mutations in NLGN3, NLGN4 and NLGN4Y in 36 pairs of affected siblings and 122 trios with autism or Asperger syndrome (140 males and 18 females). In one Swedish family with two affected brothers, one with typical autism and the other with Asperger syndrome, we identified a frameshift mutation (1186insT) in NLGN4 (Fig. 2a) . This mutation creates a stop codon at position 396, leading to premature termination of the protein before the transmembrane domain. The mutation was present in the mother but was absent in the maternal grandmother and in two maternal aunts. The unaffected maternal grandfather was deceased and could not be studied. A false paternity of the maternal grandfather was excluded by studying eight microsatellites markers from the X chromosome (data not shown). These results indicate that 1186insT is a de novo mutation in the mother. The mutation was not found in an unaffected brother or in 350 unrelated controls (250 females and 100 males).
In a second Swedish family with two affected brothers, one with typical autism and the other with Asperger syndrome, we identified a C→T transition in NLGN3. This mutation was inherited from the mother and changes a highly conserved arginine residue to cysteine (R451C) within the esterase domain (Fig. 2b) Many studies have supported a genetic etiology for autism. Here we report mutations in two X-linked genes encoding neuroligins NLGN3 and NLGN4 in siblings with autism-spectrum disorders. These mutations affect cell-adhesion molecules localized at the synapse and suggest that a defect of synaptogenesis may predispose to autism. Fig. 1 Expression of NLGN genes in the human brain. Specific RT-PCRs were carried out on total RNA from different brain regions using primers in exon 2 and 5 to analyze the different alternatively spliced transcripts. To distinguish between NLGN4 and NLGN4Y mRNA, RT-PCRs were digested by NcoI. Using specific forward primers in exon 1a (e1a) or exon 1b (e1b) and reverse primers in exon 2, the two alternative NLGN4 promoters were identified. The size of the PCR products corresponding to NLGN4 and NLGN4Y differ by 193 bp. The ages of the two males and the two females studied were 74, 42, 55 and 36 years with a post-mortem delay of 10, 21, 24 and 2 h, respectively. f, frontal cortex; tc, temporal cortex; o, occipital cortex; h, hippocampus; t, thalamus; c, cerebellum. Normal control human brains were obtained at autopsy under guidelines approved by the ethics committee. DNA amplification and RT-PCRs were carried out as described 15 . Alignment and sequences of all NLGN proteins and isoforms are available from the authors.
gliotactin) and in all sequenced esterases from mammals, fish and birds 13 . EF-hand domains are known to confer structural integrity and Ca 2+ -dependent functional properties. R451C may therefore modify the binding of neuroligins to their presynaptic partners, neurexins, as binding is only observed in the presence of Ca 2+ (ref. 14) . This mutation was absent in 200 controls (100 females and 100 males). See Supplementary Note 1 online for detailed clinical information for these families.
Three independent lines of evidence strongly suggest that mutations in NLGN3 and NLGN4 are involved in autistic spectrum disorders. First, deletions at Xp22.3 that include NLGN4 have been reported in several autistic individuals 5 . Second, the point mutations in NLGN3 and NLGN4 cause severe alterations of the predicted protein structure. Third, a mutation in NLGN4 appeared de novo in one affected individual's mother. Among the various proteins involved in the establishment of the neural networks, cell-adhesion molecules are essential factors for the identification of the appropriate partner cell and the formation of a functional synapse. Therefore, we hypothesize that a defect in NLGN3 or NLGN4 may abolish formation, stabilization or recognition of specific synapses essential for the communication processes that are deficient in individuals with autistic spectrum disorder.
URL. All primers used in this study are available on request or at http://www.im3.inserm.fr/ autism/Recherche.htm. 
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